Ovarian cancer (OC) is the seventh most commonly diagnosed cancer among women in the
world and the tenth most common in China. Epithelial OC is the most predominant …

Financial Disclosure Prof. Menon has stock ownership and has received research funding
from Abcodia Ltd, a UCL spinout company with an interest in biomarkers and commercial …

In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and
14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society …

Background: Recent genetic and morphologic studies have challenged the traditional view
on the pathogenesis of ovarian cancer; suggesting that ovarian cancer predominantly arises …

BRCA1-and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is
characterized by an increased risk for female and male breast cancer, ovarian cancer …

Mortality from ovarian cancer may be dramatically reduced with the implementation of
attainable prevention strategies. The new understanding of the cells of origin and the …

Little is known regarding the early aspects of ovarian carcinogenesis. As a consequence,
the identification of women at risk for the disease is based primarily on clinical grounds, with …

Background Various factors—including age, family history, inflammation, reproductive
factors, and tubal ligation—modulate the risk of ovarian cancer. In this study, our aim was to …

Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies
have a relatively poor prognosis and collectively remain the most deadly of all gynecologic …

Ovarian cancer (OC) is the most lethal gynaecological malignancy. The search for a widely
affordable and accessible screening strategy to reduce mortality from OC is still ongoing …